Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gabriela Gautier-Vargas
Observed names:
G. Gautier-Vargas,
G. Gautier‐Vargas,
Gabriela Gautier,
Gabriela Gautier -Vargas,
Gabriela Gautier Vargas
Institutions:
Inserm,
Hôpitaux Universitaires de Strasbourg,
Université de Strasbourg
Observed institutions:
Inserm,
Hôpitaux Universitaires de Strasbourg,
Hôpital Civil, Strasbourg,
Immuno-Rhumathologie moléculaire,
Université de Strasbourg
ORCID:
0000-0001-9377-1055
Observed ORCID:
0000-0001-9377-1055
OpenAlex ID:
A5057958868
Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses
2021
·
Ilies Benotmane
, Gabriela Gautier
, et al.
·
JAMA
·
338
PDF
Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine
2021
·
Ilies Benotmane
, Gabriela Gautier-Vargas
, et al.
·
Kidney International
·
190
PDF
Weak anti–SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients
2021
·
Ilies Benotmane
, Gabriela Gautier-Vargas
, et al.
·
Kidney International
·
160
PDF
Cytokine release syndrome‐associated encephalopathy in patients with COVID‐19
2020
·
P. Perrin
, N. Collongues
, et al.
·
European Journal of Neurology
·
155
PDF
Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients
2022
·
Xavier Charmetant
, Maxime Espi
, et al.
·
Science Translational Medicine
·
88
In-depth virological assessment of kidney transplant recipients with COVID-19
2020
·
Ilies Benotmane
, Gabriela Gautier Vargas
, et al.
·
American Journal of Transplantation
·
81
Breakthrough COVID-19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipients
2022
·
Ilies Benotmane
, Aurélie Velay
, et al.
·
American Journal of Transplantation
·
73
First case of COVID-19 in a kidney transplant recipient treated with belatacept
2020
·
David Marx
, Bruno Moulin
, et al.
·
American Journal of Transplantation
·
68
Intravenous immunoglobulin as a preventive strategy against BK virus viremia and BKV-associated nephropathy in kidney transplant recipients—Results from a proof-of-concept study
2020
·
Ilies Benotmane
, Morgane Solis
, et al.
·
American Journal of Transplantation
·
59
PDF
Pre-exposure prophylaxis with 300 mg Evusheld elicits limited neutralizing activity against the Omicron variant
2022
·
Ilies Benotmane
, Aurélie Velay
, et al.
·
Kidney International
·
57
PDF
Biomarkers of Cytokine Release Syndrome Predict Disease Severity and Mortality From COVID-19 in Kidney Transplant Recipients
2020
·
Ilies Benotmane
, Peggy Perrin
, et al.
·
Transplantation
·
51
Pre-existing donor-specific antibodies are detrimental to kidney allograft only when persistent after transplantation
2016
·
Sophie Caillard
, Camille Becmeur
, et al.
·
Transplant International
·
40
Recent Changes in Chronic Kidney Disease–Mineral and Bone Disorders and Associated Fractures After Kidney Transplantation
2016
·
Peggy Perrin
, Clotilde Kiener
, et al.
·
Transplantation
·
40
Early Administration of Anti–SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients
2022
·
Juliette Gueguen
, Charlotte Colosio
, et al.
·
Kidney International Reports
·
38
PDF
SARS-CoV-2 viral dynamics in immunocompromised patients
2020
·
Sophie Caillard
, Ilies Benotmane
, et al.
·
American Journal of Transplantation
·
30
Strong antibody response after a first dose of a SARS-CoV-2 mRNA-based vaccine in kidney transplant recipients with a previous history of COVID-19
2021
·
Ilies Benotmane
, Gabriela Gautier -Vargas
, et al.
·
American Journal of Transplantation
·
28
PDF
Persistence of SARS-CoV-2 antibodies in kidney transplant recipients
2020
·
Ilies Benotmane
, Gabriela Gautier Vargas
, et al.
·
American Journal of Transplantation
·
22
Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab
2020
·
Gabriela Gautier-Vargas
, Clement Baldacini
, et al.
·
Kidney International
·
21
PDF
Occurrence of De novo Donor-Specific Antibodies After COVID-19 in Kidney Transplant Recipients Is Low Despite Immunosuppression Modulation
2022
·
Christophe Masset
, Gabriela Gautier-Vargas
, et al.
·
Kidney International Reports
·
20
PDF
Pregnancy in a Kidney Transplant Woman Under Treatment With Eculizumab for Atypical Hemolytic Uremic Syndrome: Is It Safe?
2019
·
Anna Duval
, Jérôme Olagne
, et al.
·
Kidney International Reports
·
15
PDF
Does a Useful Test Exist to Properly Evaluate the Pathogenicity of Donor-specific Antibodies? Lessons From a Comprehensive Analysis in a Well-studied Single-center Kidney Transplant Cohort
2019
·
Gabriela Gautier Vargas
, Jérome Olagne
, et al.
·
Transplantation
·
14
Eculizumab as a therapeutic approach for severe crescentic recurrence of immunoglobulin A nephropathy after kidney transplantation
2023
·
Anna Duval
, Jérôme Olagne
, et al.
·
American Journal of Transplantation
·
13
PDF
Tixagevimab-cilgavimab as an Early Treatment for COVID-19 in Kidney Transplant Recipients
2023
·
Ilies Benotmane
, Jérôme Olagne
, et al.
·
Transplantation
·
11
PDF
Legionnaires Disease in Solid Organ Transplant Recipients
2023
·
Guillaume Thizy
, Adrien Flahault
, et al.
·
CHEST Journal
·
9
PDF
COVID-19 in a kidney transplant recipient treated with eculizumab for atypical hemolytic uremic syndrome: a case report
2021
·
Noëlle Cognard
, Gabriela Gautier-Vargas
, et al.
·
Journal of Nephrology
·
9
PDF
Show more works
View as search
Works count:
42
Citation count:
1,643
H-index:
19
I10-index:
23
Year
Topic
Type